Herpes zoster by reactivated vaccine varicella zoster virus in a healthy child

Barbara Uebe, Andreas Sauerbrei, Stefan Burdach, Gerd Horneff

Publikation: Beitrag in FachzeitschriftArtikelBegutachtung

65 Zitate (Scopus)

Abstract

Varicella can be prevented by vaccination using the live-attenuated Oka vaccine strain of varicella zoster virus (VZV). Only mild breakthrough disease has been reported in seronegative vaccinees when exposed to the wild-type virus. The latent varicella vaccine virus has rarely caused herpes zoster in childhood and adolescence. We report a healthy 2-year-old girl who developed an impressive herpes zoster infection 16 months after vaccination, localised in three cervical dermatoma. As causative virus, VZV vaccine strain was identified by polymerase chain reaction and analysis of restriction fragment length polymorphisms of the amplified products. Conclusion: vaccine varicella zoster virus can occasionally reactivate in healthy children and present as herpes zoster. Virus characterisation is necessary to identify the strain and provide information on the incidence of occurrence.

OriginalspracheEnglisch
Seiten (von - bis)442-444
Seitenumfang3
FachzeitschriftEuropean Journal of Pediatrics
Jahrgang161
Ausgabenummer8
DOIs
PublikationsstatusVeröffentlicht - 2002
Extern publiziertJa

Fingerprint

Untersuchen Sie die Forschungsthemen von „Herpes zoster by reactivated vaccine varicella zoster virus in a healthy child“. Zusammen bilden sie einen einzigartigen Fingerprint.

Dieses zitieren